[ad_1]
Text size
Ibogaine Clinic Has Found the Solution to Beating the Opioid Epidemic
[ad_1]
INSCMagazine: Get Social!
Post Views:
298
David Dardashti of Ibogaine Clinic has pioneered an alternative treatment using Ibogaine (extracted from Iboga root bark, a natural psychedelic with dissociative properties. Ibogaine in its purest form offers true perception of one’s brain body and subconscious, possesses anti addictive properties and is not psychedelic) for the treatment of the highly potent and addictive Suboxone, Methadone, Subutex and Kratom drugs. ...
HPU's Dr. Scott Hemby Receives More Than $1 Million in Collaborative NIH Funding
[ad_1]
The grant entitled “Chemistry and Pharmacology of Iboga Alkaloids” is funded … Ibogaine has been used for its ability to interrupt opiate and cocaine …
[ad_2]
Source link
The Role of Psychedelic Plant Medicines in Addiction Treatment
[ad_1]
Psychedelic plant medicines have the potential to help many people who are in recovery from substance use disorder dig deep into the roots of their addiction and come out of the other side. Plant medicines like psilocybin, ayahuasca, and particularly ibogaine, have demonstrated unprecedented results for those who use them as a tool on their recovery journey.
While the legal status of many of these substances is still murky (depending on where you ...
Pharmather Secures Exclusive Rights to Novel Microneedle Delivery Technology for Psychedelic Pharmaceuticals
[ad_1]
TORONTO, Oct. 22, 2020 (GLOBE NEWSWIRE) — Pharmather Inc., a wholly-owned subsidiary of Newscope Capital Corporation (“Pharmather” or the “Company”) (CSE: PHRM) and a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals, is pleased to announce that the Company has entered into an exclusive license agreement (the “Agreement”) with BioRAE, Inc., for the development and commercialization of a novel biocompatible and biodegradable gelatin methacryloyl microneedle (“GelMA-MN”) delivery ...